Chronic kidney disease with coronary aretry disease or peripheral artery disease
Conditions
Interventions
RenalGuard group
Sponsors
Yokohama Sakae Kyosai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Male or non-pregnant female equal or greater than the age 20 years old and is able to provide informed consent. Subject is scheduled to undergo an catheterization procedure that is expected to use at least 75 ml of intraarterial contrast. Subject has moderate to severe kidney impairement-eGFR<45 ml/min/1.73m2 and more than 30 % of ejection fraction of left ventricle.
Exclusion criteria
Exclusion criteria: Class 3 or 4 chronic heart failure. Subject is anuric or has undergone renal replacement therapy, or has a known inability to have a Foley catheter placed. Subject has received contrast within 7 days of procedure. Subject has a known hypersensitivity to furosemide and/or the contrast agent being used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined incidence of contrast-induced nephropathy (CIN) and serious in-hospital therapy-related adverse events | — |
Countries
Japan
Contacts
Public ContactTsuyoshi Nozue
Yokohama Sakae Kyosai Hospital Divison of Cardiology, Department of Internal Medicine
Outcome results
None listed